Literature DB >> 2690152

The families of cognition enhancers.

W Fröstl1, L Maître.   

Abstract

An attempt has been made to classify the numerous drugs used to treat cognition deficits according to their chemical structures and to their main physiological effects. Particular emphasis has been given to the following families: Piracetam-type, Co-dergocrine-type and vincamine-type compounds; cholinergic agents, psychostimulants, vasodilators, antianoxic agents, peptides, growth factors and gangliosides. Compounds described in the scientific literature and in patents are presented. Reference has been made to preclinical and clinical studies (973 quotations from original articles, 100 quotations of reviews and books).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2690152     DOI: 10.1055/s-2007-1014626

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  3 in total

Review 1.  Cognition enhancers in age-related cognitive decline.

Authors:  W J Riedel; J Jolles
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

2.  The Psychonauts' World of Cognitive Enhancers.

Authors:  Flavia Napoletano; Fabrizio Schifano; John Martin Corkery; Amira Guirguis; Davide Arillotta; Caroline Zangani; Alessandro Vento
Journal:  Front Psychiatry       Date:  2020-09-11       Impact factor: 4.157

3.  The cognition-enhancing activity of E1R, a novel positive allosteric modulator of sigma-1 receptors.

Authors:  L Zvejniece; E Vavers; B Svalbe; R Vilskersts; I Domracheva; M Vorona; G Veinberg; I Misane; I Stonans; I Kalvinsh; M Dambrova
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.